Sale!

FLNB Gene Atelosteogenesis Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FLNB Gene Atelosteogenesis Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the FLNB gene, which are responsible for Atelosteogenesis Type 1, a rare skeletal disorder. This condition is characterized by severe bone abnormalities, including poorly developed bones in the spine, ribcage, and limbs, leading to significant physical deformities and, in many cases, prenatal or early postnatal fatality. The test involves analyzing the patient’s DNA to detect mutations in the FLNB gene that signal the presence of Atelosteogenesis Type 1, providing crucial information for diagnosis, management, and genetic counseling.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the FLNB Gene Atelosteogenesis Type 1 Genetic Test is priced at 4400 AED. This cost reflects the sophisticated technology and expertise required to accurately identify the specific genetic mutations associated with this condition. For families with a history of skeletal disorders or for individuals showing symptoms related to Atelosteogenesis Type 1, this test offers a vital resource for confirming the diagnosis, understanding the risk of recurrence in future pregnancies, and exploring potential treatment or management options.

Description

FLNB Gene Atelosteogenesis type 1 Genetic Test

Components: FLNB Gene Atelosteogenesis type 1 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FLNB Gene Atelosteogenesis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLNB Gene Atelosteogenesis type 1 NGS Genetic DNA Test gene FLNB

Test Details:

The FLNB gene is responsible for providing instructions for making a protein called filamin B. Mutations in the FLNB gene can cause a rare genetic disorder called atelosteogenesis type 1. Atelosteogenesis type 1 is a severe skeletal disorder characterized by abnormal bone development and growth. Individuals with this condition typically have short limbs, a small chest, and a narrow ribcage. They may also have joint dislocations, clubfoot, and other skeletal abnormalities. Additionally, individuals with atelosteogenesis type 1 may have respiratory difficulties and may not survive beyond infancy or early childhood.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It allows for the detection of specific genetic mutations associated with certain disorders, including atelosteogenesis type 1. NGS genetic testing can identify mutations in the FLNB gene, helping to confirm a diagnosis of atelosteogenesis type 1.

The genetic test involves obtaining a sample of the individual’s DNA, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology, which reads the individual’s genetic code and identifies any mutations in the FLNB gene.

The results of the test can help healthcare professionals diagnose atelosteogenesis type 1 and provide appropriate medical management and genetic counseling for affected individuals and their families.

Test Name	FLNB Gene Atelosteogenesis type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FLNB Gene Atelosteogenesis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLNB Gene Atelosteogenesis type 1 NGS Genetic DNA Test gene FLNB
Test Details	The FLNB gene is responsible for providing instructions for making a protein called filamin B. Mutations in the FLNB gene can cause a rare genetic disorder called atelosteogenesis type 1. Atelosteogenesis type 1 is a severe skeletal disorder characterized by abnormal bone development and growth. Individuals with this condition typically have short limbs, a small chest, and a narrow ribcage. They may also have joint dislocations, clubfoot, and other skeletal abnormalities. Additionally, individuals with atelosteogenesis type 1 may have respiratory difficulties and may not survive beyond infancy or early childhood. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It allows for the detection of specific genetic mutations associated with certain disorders, including atelosteogenesis type 1. NGS genetic testing can identify mutations in the FLNB gene, helping to confirm a diagnosis of atelosteogenesis type 1. The genetic test involves obtaining a sample of the individual’s DNA, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology, which reads the individual’s genetic code and identifies any mutations in the FLNB gene. The results of the test can help healthcare professionals diagnose atelosteogenesis type 1 and provide appropriate medical management and genetic counseling for affected individuals and their families.